These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18503945)

  • 1. Pro: hydroxyethyl starch is preferable to albumin in the perioperative management of cardiac patients.
    James MF
    J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):482-4. PubMed ID: 18503945
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
    Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
    Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of various colloidal solutions on pulmonary oxygenizing function in patients with acute lung lesion].
    Krasheninnikov SV; Levit AL; Leĭderman IN; Malkova OG
    Anesteziol Reanimatol; 2007; (3):20-2. PubMed ID: 17684983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Con: starches are not preferable to albumin during cardiac surgery: a contrary opinion.
    Green RS; Hall RI
    J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):485-91. PubMed ID: 18503946
    [No Abstract]   [Full Text] [Related]  

  • 5. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
    Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
    Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethyl starch 130/0.4: safe in cardiac surgery?
    Davidson IJ
    Crit Care Med; 2008 May; 36(5):1695-6; author reply 1696. PubMed ID: 18448958
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modification of perioperative drug therapy in cardiovascular, pulmonary or metabolic disease].
    Redel A; Schwemmer U
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Feb; 43(2):144-54. PubMed ID: 18293249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative Management of Cardiovascular Medications.
    Lomivorotov VV; Efremov SM; Abubakirov MN; Belletti A; Karaskov AM
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2289-2302. PubMed ID: 29482937
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hydroxyethyl starch 450/0.7 in burn shock. Effect on edema formation].
    Steen M; Ziegelmüller P
    Unfallchirurg; 1985 Jan; 88(1):22-6. PubMed ID: 2581320
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colloids for vegetarians.
    Eipe N; Oduro-Donminah A
    Anaesthesia; 2005 May; 60(5):520. PubMed ID: 15819786
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic control and clinical outcomes in the perioperative setting.
    Aronson S; Varon J
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):509-25. PubMed ID: 21493093
    [No Abstract]   [Full Text] [Related]  

  • 13. How possibly are we to choose albumin or hydroxyethyl starch?
    Hanna BD
    Crit Care Med; 2009 Feb; 37(2):788-9. PubMed ID: 19325392
    [No Abstract]   [Full Text] [Related]  

  • 14. The pros and cons of hydroxyethyl starch solutions.
    Vincent JL
    Anesth Analg; 2007 Mar; 104(3):484-6. PubMed ID: 17312191
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of perioperative cardiac complications in non-cardiac surgery: an evidence-based guideline].
    Damen J; Hagemeijer JW; van den Broek L; Poldermans D;
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2612-6. PubMed ID: 19102436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic impairment after infusion of hydroxyethyl starch, gelatin, and albumin.
    Bamgbade OA; Dorje P; Caldwell MD
    Anesth Analg; 2007 May; 104(5):1295-6; author reply 1296. PubMed ID: 17456695
    [No Abstract]   [Full Text] [Related]  

  • 17. Refining perioperative glucose management in patients experiencing, or at risk for, ischemic brain injury.
    Lanier WL; Pasternak JJ
    Anesthesiology; 2009 Mar; 110(3):456-8. PubMed ID: 19212258
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
    Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
    J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perioperative beta-blockade for reduction of cardiovascular complications in non-cardiac surgery: advantages and disadvantages].
    Koelemay MJ; Legemate DA
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2603-5. PubMed ID: 19102434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyethyl starches should not be used in critically ill patients.
    Johnston M; Clarke L
    J R Army Med Corps; 2008 Sep; 154(3):214. PubMed ID: 19205089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.